title: Modelling the Impact of Persistence Improvements with an Electronic Injection Device on Escalation to 2nd Line Treatment in Patients with Relapsing Remitting Multiple Sclerosis (RRMS).
authors.affiliation: EMD Serono, Inc., Rockland, MA, USA.
authors.forename: D M
authors.initials: DM
authors.lastname: Meletiche
authors.affiliation: CBPartners, New York City, NY, USA.
authors.forename: T
authors.initials: T
authors.lastname: Rutkowski
authors.affiliation: CBPartners, San Francisco, CA, USA.
authors.forename: M A
authors.initials: MA
authors.lastname: Martin de Bustamante
authors.affiliation: CBPartners, New York, NY, USA.
authors.forename: C A
authors.initials: CA
authors.lastname: Chowdhury
authors.affiliation: CBPartners, New York City, NY, USA.
authors.forename: R
authors.initials: R
authors.lastname: Beckerman